| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/13/2011 | US8076454 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 12/13/2011 | US8076306 Compositions and their uses directed to hepcidin |
| 12/13/2011 | US8076163 Isoelectric particles and uses therefore |
| 12/13/2011 | US8076159 Ligand-regulable transactivation systems, methods of use thereof, methods of detecting estrogen receptor ligands, and methods of differentiating estrogen receptor ligand agonists and antagonists |
| 12/13/2011 | US8076138 Evolution of whole cells and organisms by recursive sequence recombination |
| 12/13/2011 | US8076115 Polypeptides having phytase activity and polynucleotides encoding same |
| 12/13/2011 | US8076114 Cytochrome P450 oxygenases |
| 12/13/2011 | US8076105 Device and method for high-throughput quantification of MRNA from whole blood |
| 12/13/2011 | US8076099 Biomarkers of Francisella infection |
| 12/13/2011 | US8076098 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/13/2011 | US8076090 Label free biosensors and cells |
| 12/13/2011 | US8076085 Methods and means relating to hepatitis B infection |
| 12/13/2011 | US8076084 Method of predicting metastatic potential prognosis or overall survival of cancer patients |
| 12/13/2011 | US8076083 Screening methods involving the detection of short-lived proteins |
| 12/13/2011 | US8076082 Methods for identifying multiple DNA alteration markers in a large background of wild-type DNA |
| 12/13/2011 | US8076081 Systems, methods, and compositions for detection of human papilloma virus in biological samples |
| 12/13/2011 | US8076080 Nucleic acid amplification primers for detecting cytokeratins and examination method with the use of the primers |
| 12/13/2011 | US8076079 Single molecule detection using molecular motors |
| 12/13/2011 | US8076078 Cystic fibrosis gene mutations |
| 12/13/2011 | US8076077 Compositions and methods for prognosis and therapy of liver cancer |
| 12/13/2011 | US8076076 Systems and methods for processing hybrid seed |
| 12/13/2011 | US8076075 System and method for diagnosis of neuropsychiatric disorders |
| 12/13/2011 | US8076074 Balanced translocation in comparative hybridization |
| 12/13/2011 | US8076073 Cholesterol and hedgehog signaling |
| 12/13/2011 | US8076072 Nucleic acid labeling compounds |
| 12/13/2011 | US8076071 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules |
| 12/13/2011 | US8076070 Genome-wide chromosome conformation capture |
| 12/13/2011 | US8076069 Method for the treatment of a sample containing biomolecules |
| 12/13/2011 | US8076068 Method for determining immunostimulatory activity of RNA oligonucleotides |
| 12/13/2011 | US8076067 Probe-antiprobe compositions and methods for DNA or RNA detection |
| 12/13/2011 | US8076066 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy |
| 12/13/2011 | US8076065 Methods and compositions for assessment of pulmonary function and disorders |
| 12/13/2011 | US8076064 Method of treatment of RNA sample |
| 12/13/2011 | US8076063 Multiplexed methylation detection methods |
| 12/13/2011 | US8076062 Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance |
| 12/13/2011 | US8076061 Method and composition for cancer diagnosis and treatment |
| 12/13/2011 | US8076060 Administering to a human a composition containing an effective amount of an agent capable of stimulating an immunological response resulting in reduced intraocular pressure |
| 12/13/2011 | US8076035 High current density; decomposition of fuel using enzymes; generating electricity |
| 12/13/2011 | US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides |
| 12/13/2011 | US8075767 Integrated high throughput system for the analysis of biomolecules |
| 12/13/2011 | US8075760 Electrochemical cell |
| 12/13/2011 | CA2734230C High yielding soybean variety xb29z11 |
| 12/13/2011 | CA2734228C High yielding soybean variety xr27f11 |
| 12/13/2011 | CA2734156C High yielding soybean variety xb15c11 |
| 12/13/2011 | CA2734153C High yielding soybean variety xb25x11 |
| 12/13/2011 | CA2734150C High yielding soybean variety xb14g11 |
| 12/13/2011 | CA2734148C High yielding soybean variety xb25q11 |
| 12/13/2011 | CA2734020C High yielding soybean variety 92y74 |
| 12/13/2011 | CA2734015C High yielding soybean variety xb12d11 |
| 12/13/2011 | CA2734013C High yielding soybean variety xb06m11 |
| 12/13/2011 | CA2734000C High yielding soybean variety xb04q11 |
| 12/13/2011 | CA2733981C High yielding soybean variety xb25y11 |
| 12/13/2011 | CA2733962C High yielding soybean variety xb32j11 |
| 12/13/2011 | CA2733960C High yielding soybean variety xb23k11 |
| 12/13/2011 | CA2733957C High yielding soybean variety xb16r11 |
| 12/13/2011 | CA2733955C High yielding soybean variety xb17m11 |
| 12/13/2011 | CA2733953C High yielding soybean variety xb22p11 |
| 12/13/2011 | CA2733887C High yielding soybean variety 900y61 |
| 12/13/2011 | CA2733880C High yielding soybean variety 900y81 |
| 12/13/2011 | CA2475821C Group b streptococcus antigens |
| 12/13/2011 | CA2446197C Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an act polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances |
| 12/13/2011 | CA2436357C Light scattering determination of treatment potencies |
| 12/13/2011 | CA2418655C Use of grf1 protein and cells expressing grf1 protein for screening molecules |
| 12/13/2011 | CA2384901C Quantitative detection of viruses by light scattering |
| 12/13/2011 | CA2383225C Recombinant adenoviruses preparation and adenovirus banks |
| 12/08/2011 | WO2011153552A2 Mutant parasites for use as vaccines and platforms for screening for compounds |
| 12/08/2011 | WO2011153522A2 Compounds and methods for fret based measurement of enzyme activity |
| 12/08/2011 | WO2011153501A2 Methods for improving inflammatory bowel disease diagnosis |
| 12/08/2011 | WO2011153354A1 Methods and kits for in situ detection of nucleotide sequences |
| 12/08/2011 | WO2011153325A2 Gene expression profiling for predicting the response to immunotherapy and/or the survivability of melanoma subjects |
| 12/08/2011 | WO2011153287A2 Materials and methods for diagnosing and predicting the course of prostate cancer |
| 12/08/2011 | WO2011153244A1 Sample processing method and device |
| 12/08/2011 | WO2011153234A2 Methods of inhibiting alu rna and therapeutic uses thereof |
| 12/08/2011 | WO2011153224A2 Diagnostic methods and compositions for treatment of cancer |
| 12/08/2011 | WO2011153121A2 A soluble and stable human 5-lipoxygenase |
| 12/08/2011 | WO2011153097A1 Methods and kits for predicting a vaccine response |
| 12/08/2011 | WO2011152983A2 Fluid flow contour control using flow resistance |
| 12/08/2011 | WO2011152899A1 System and methods for determining drug resistance in microorganisms |
| 12/08/2011 | WO2011152884A2 14 gene signature distinguishes between multiple myeloma subtypes |
| 12/08/2011 | WO2011152883A2 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics |
| 12/08/2011 | WO2011152722A2 Cloning and exploitation of a functional r-gene from solanum x edinense |
| 12/08/2011 | WO2011152554A1 Method for producing tumor cell |
| 12/08/2011 | WO2011152503A1 Treatment drug for autoimmune diseases and allergic diseases |
| 12/08/2011 | WO2011152272A1 Method of determining the risk of adverse effects of irinotecan, and kit therefore |
| 12/08/2011 | WO2011152071A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 12/08/2011 | WO2011152043A1 Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organisms |
| 12/08/2011 | WO2011152012A1 Method for testing the severity of an illness |
| 12/08/2011 | WO2011151793A1 Detection and enumeration of microorganisms |
| 12/08/2011 | WO2011151777A1 Method for the preparation and amplification of representative and strand- specific libraries of cdna for high throughput sequencing, use thereof, kit and cartridges for automation kit |
| 12/08/2011 | WO2011151586A1 Method for genotyping staphylococcus aureus |
| 12/08/2011 | WO2011151498A1 Methods and reagents for the detection and quantification of bacteria resistant to tetracyclines |
| 12/08/2011 | WO2011151473A1 Composition, method and kit for detecting fungi and yeasts by means of sequencing |
| 12/08/2011 | WO2011151427A1 Stabilization of nucleic acids in cell material-containing biological samples |
| 12/08/2011 | WO2011151405A1 Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence |
| 12/08/2011 | WO2011151404A1 Method for specific detection of classical swine fever virus |
| 12/08/2011 | WO2011151335A1 High-throughput method for determining the presence of papillomavirus-neutralizing antibodies in a sample |
| 12/08/2011 | WO2011151321A1 Asf1b as a prognosis marker and therapeutic target in human cancer |
| 12/08/2011 | WO2011151061A1 Al035301, a biomarker for breast cancer |
| 12/08/2011 | WO2011150999A1 A genetically modified bacterium of the species listeria monocytogenes |
| 12/08/2011 | WO2011150976A1 Method and kit for the prognosis of colorectal cancer |